Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
- Conditions
- Chronic Kidney Disease stage4
- Interventions
- Drug: KT-301 (formerly US-APR2020)
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 600
- Registration Number
- NCT05407389
- Locations
- 🇺🇸
Jadedstone Clinical Research, Silver Spring, Maryland, United States
🇺🇸Kidney Michigan, Saginaw, Michigan, United States
🇺🇸South Carolina Clinical Research, Orangeburg, South Carolina, United States
Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 630
- Registration Number
- NCT04913272
- Locations
- 🇺🇸
Kidney Michigan, Saginaw, Michigan, United States
🇺🇸Jadedstone Clinical Research, Silver Spring, Maryland, United States
🇺🇸South Carolina Clinical Research, Orangeburg, South Carolina, United States
Observational Study of Kibow Biotics in Dialysis Patients
- Conditions
- Chronic Kidney Failure
- Interventions
- Dietary Supplement: Kibow Biotics
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT01450670
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis
- Conditions
- Chronic Kidney Disease
- Interventions
- Dietary Supplement: Kibow Biotics
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT01450709
- Locations
- 🇺🇸
Parkside Dialysis Clinic at Downstate Medical Center, Brooklyn, New York, United States
Observational Study of Kibow Biotics in Chronic Kidney Failure Patients
- Conditions
- Chronic Kidney Failure
- Interventions
- Dietary Supplement: Kibow Biotics/Renadyl
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 31
- Registration Number
- NCT01450657
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Pilot-Scale Clinical Trials of Kibow Biotics® in Chronic Kidney Failure
- Conditions
- Chronic Kidney Failure
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 180
- Registration Number
- NCT00760162
- Locations
- 🇺🇸
SUNY DownState Medical Center-Renakl Division, Brooklyn, New York, United States
🇺🇸Downstate Medical Center,HSCB, State University of New York, Brooklyn, New York, United States